Abbott Laboratories (ETR:ABL)
Germany flag Germany · Delayed Price · Currency is EUR
113.98
+0.22 (0.19%)
Apr 24, 2025, 5:35 PM CET

Abbott Laboratories Statistics

Total Valuation

ETR:ABL has a market cap or net worth of EUR 198.09 billion. The enterprise value is 204.73 billion.

Market Cap 198.09B
Enterprise Value 204.73B

Important Dates

The last earnings date was Wednesday, April 16, 2025.

Earnings Date Apr 16, 2025
Ex-Dividend Date Apr 15, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -0.07%
Shares Change (QoQ) +0.06%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 1.72B

Valuation Ratios

The trailing PE ratio is 15.92.

PE Ratio 15.92
Forward PE n/a
PS Ratio 5.06
PB Ratio 4.47
P/TBV Ratio 11.96
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 16.45
EV / Sales 5.50
EV / EBITDA 20.47
EV / EBIT 29.89
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.32
Debt / EBITDA 1.34
Debt / FCF n/a
Interest Coverage 14.23

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 8.32%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 343,655
Profits Per Employee 109,165
Employee Count 114,000
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +13.35% in the last 52 weeks. The beta is 0.80, so ETR:ABL's price volatility has been lower than the market average.

Beta (5Y) 0.80
52-Week Price Change +13.35%
50-Day Moving Average 120.85
200-Day Moving Average 110.26
Relative Strength Index (RSI) 44.71
Average Volume (20 Days) 606

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 2.94

Income Statement

In the last 12 months, ETR:ABL had revenue of EUR 39.18 billion and earned 12.44 billion in profits. Earnings per share was 7.13.

Revenue 39.18B
Gross Profit 21.91B
Operating Income 7.20B
Pretax Income 6.80B
Net Income 12.44B
EBITDA 10.18B
EBIT 7.20B
Earnings Per Share (EPS) 7.13
Full Income Statement

Balance Sheet

The company has 7.37 billion in cash and 14.13 billion in debt, giving a net cash position of -6.76 billion.

Cash & Cash Equivalents 7.37B
Total Debt 14.13B
Net Cash -6.76B
Net Cash Per Share n/a
Equity (Book Value) 44.32B
Book Value Per Share 25.47
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 55.92%, with operating and profit margins of 18.39% and 31.89%.

Gross Margin 55.92%
Operating Margin 18.39%
Pretax Margin 17.37%
Profit Margin 31.89%
EBITDA Margin 25.98%
EBIT Margin 18.39%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 2.10, which amounts to a dividend yield of 1.85%.

Dividend Per Share 2.10
Dividend Yield 1.85%
Dividend Growth (YoY) 7.50%
Years of Dividend Growth 6
Payout Ratio n/a
Buyback Yield 0.07%
Shareholder Yield 1.92%
Earnings Yield 6.28%
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a